JoséMaríaRojo, Pilar Portolés
118
49. Tzenaki, N.; & Papakonstanti, E. A. p110
δ
PI3 kinase pathway: emerging roles in cancer.
FrontOncol
3
, 40(2013).
50. Barber, D. F.; Alvarado-‐Kristensson, M.; Gonzalez-‐Garcia, A.; Pulido, R.; & Carrera, A. C.
PTEN regulation, a novel function for the p85 subunit of Phosphoinositide 3-‐Kinase.
ScienceSTKE
2006
, pe49-‐50(2006).
51. Downward, J.; &Weigelt, B. Genomic determinants of PI3K pathway inhibitor response in
cancer.
FrontOncol
2
, 109(2012).
52. Rommel, C.; Camps, M.; & Ji, H. PI3K
δ
and PI3K
γ
: Partners in crime in inflammation in
rheumatoidarthritis andbeyond?
NatRev Immunol
7
, 191-‐201(2007).
53. Gamper, C. J.; & Powell, J. D. All PI3Kinase signaling is not mTOR: Dissecting mTOR-‐
dependent and independent signalingpathways inTcells.
Front Immunol
3
(2012).
54. Thomson, A. W.; Turnquist, H. R.; & Raimondi, G. Immunoregulatory functions of mTOR
inhibition.
NatRev Immunol
9
, 324-‐337(2009).
55. Ghigo, A.; Damilano, F.; Braccini, L.; &Hirsch, E. PI3K inhibition in inflammation: Toward
tailored therapies for specificdiseases.
BioEssays
32
, 185-‐196(2010).
56. Okkenhaug, K.; Ali, K.; &Vanhaesebroeck, B. Antigen receptor signalling: Adistinctive role
for thep110
δ
isoformof PI3K.
Trends Immunol
28
, 80-‐87(2007).
57. Fruman, D. A.; Snapper, S. B.; Yballe, C. M.; Davidson, L.; Yu, J. Y.; Alt, F. W.; &Cantley, L. C.
Impaired B cell development and proliferation in absence of phosphoinositide 3-‐kinase
p85
α
Science
283
, 393-‐397(1999).
58. Suzuki, H.; Terauchi, Y.; Fujiwara, M.; Aizawa, S.; Yazaki, Y.; Kadowaki, T.; &Koyasu, S.
Xid
-‐
like immunodeficiency inmicewithdisruptionof thep85
α
subunit of phosphoinositide3-‐
kinase.
Science
283
, 390-‐392(1999).
59. Chen, D.; Mauvais-‐Jarvis, F.; Bluher, M.; Fisher, S. J.; Jozsi, A.; Goodyear, L. J.; Ueki, K.; & al.
p50
α
/p55
α
phosphoinositide 3-‐kinase knockout mice exhibit enhanced insulin
sensitivity.
Mol Cell Biol
24
, 320-‐329(2004).
60. Deane, J. A.; Trifilo, M. J.; Yballe, C. M.; Choi, S.; Lane, T. E.; &Fruman, D. A. EnhancedT cell
proliferation in mice lacking the p85
β
subunit of phosphoinositide 3-‐kinase.
J Immunol
172
, 6615-‐6625(2004).
61. Matheu, M. P.; Deane, J. A.; Parker, I.; Fruman, D. A.; & Cahalan, M. D. Class IA
phosphoinositide 3-‐kinase modulates basal lymphocyte motility in the lymph node.
J
Immunol
179
, 2261-‐2269(2007).
62. Suire, S.; Condliffe, A. M.; Ferguson, G. J.; Ellson, C. D.; Guillou, H.; Davidson, K.;Welch, H.; &
al. G
βγ
s and the Ras binding domain of p110
γ
are both important regulators of PI3K
γ
signalling inneutrophils.
Nat Cell Biol
8
, 1303-‐1309(2006).
63. Ramadani, F.; Bolland, D. J.; Garcon, F.; Emery, J. L.; Vanhaesebroeck, B.; Corcoran, A. E.; &
Okkenhaug, K. The PI3K isoforms p110
α
and p110
δ
are essential for pre-‐B cell receptor
signalingandBcell development.
Sci Signal
3
, ra60(2010).
64. Clayton, E.; Bardi, G.; Bell, S. E.; Chantry, D.; Downes, C. P.; Gray, A.; Humphries, L. A.; &al. A
crucial role for the p110
δ
subunit of phosphatidylinositol 3-‐kinase in B cell development
andactivation.
J ExpMed
196
, 753-‐763(2002).
65. Jou, S.-‐T.; Carpino, N.; Takahashi, Y.; Piekorz, R.; Chao, J.-‐R.; Carpino, N.; Wang, D.; & al.
Essential, nonredundant role for the phosphoinositide 3-‐kinase p110
δ
in signaling by the
B-‐cell receptor complex.
Mol Cell Biol
22
, 8580-‐8591(2002).
66. Okkenhaug, K.; Bilancio, A.; Farjot, G.; Priddle, H.; Sancho, S.; Peskett, E.; Pearce, W.; & al.
ImpairedBandTcell antigenreceptor signaling inp110
δ
PI 3-‐kinasemutantmice.
Science
297
, 1031-‐1034(2002).
67. Zhang, T.-‐t.; Okkenhaug, K.; Nashed, B. F.; Puri, K. D.; Knight, Z. A.; Shokat, K. M.;
Vanhaesebroeck, B.; & al. Genetic or pharmaceutical blockade of p110
δ
phosphoinositide
3-‐kinaseenhances IgEproduction.
J AllergyClin Immunol
122
, 811-‐819.e812(2008).
68. Zhang, T.-‐t.;Makondo, K. J.;&Marshall, A. J. p110
δ
phosphoinositide3-‐kinase represses IgE
switchbypotentiatingBCL6expression.
J Immunol
188
, 3700-‐3708(2012).
69. Sasaki, T.; Irie-‐Sasaki, J.; Jones, R. G.; Oliveira-‐dos-‐Santos, A. J.; Stanford, W. L.; Bolon, B.;
Wakeham, A.; & al. Function of PI3K
γ
in thymocyte development, T cell activation, and
neutrophilmigration.
Science
287
, 1040-‐1046(2000).
70. Ji, H.; Rintelen, F.;Waltzinger, C.; BertschyMeier, D.; Bilancio, A.; Pearce,W.;Hirsch, E.;&al.
Inactivation of PI3K
γ
and PI3K
δ
distorts T-‐cell development and causes multiple organ
inflammation.
Blood
110
, 2940-‐2947(2007).
